The results come at a tricky time for Chinese commerce businesses, given the broad sluggishness in the world’s second-largest economy.
Related Posts
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face competition from cheaper generics.
Stocks making the biggest moves midday: Urban Outfitters, Advance Auto Parts, Snowflake, Sunrun and more
These are the stocks posting the largest moves in midday trading.
Novo Nordisk posts net profit beat on Wegovy sales jump, sees growth slowdown this year
Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.